このエントリーをはてなブックマークに追加
ID 66178
著者
Miura, Kizuku Faculty of Pharmaceutical Sciences, Okayama University
Fujihara, Michiko Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Watanabe, Masaki Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Takamura, Yuta Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kawasaki, Mayu Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka
Nakano, Shogo Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka
Kakuta, Hiroki Division of Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences ORCID Kaken ID publons researchmap
抄録
High selectivity of small-molecule drug candidates for their target molecule is important to minimize potential side effects. One factor that contributes to the selectivity is the internal polarity of the ligand-binding pocket (LBP) in the target molecule, but this is difficult to measure. Here, we first confirmed that the retinoid X receptor (RXR) agonist 6-(ethyl(1-isobutyl-2-oxo-4-(trifluoromethyl)-1,2-dihydroquinolin-7-yl)amino)nicotinic acid (NEt-iFQ, 1) exhibits fluorescence solvatochromism, i.e., its Stokes shift depends on the polarity of the solvent, and then we utilized this property to directly measure the internal polarity of the RXRα-LBP. The Stokes shift of 1 when bound to the RXRα-LBP corresponded to that of 1 in chloroform solution. This finding is expected to be helpful for designing RXR-selective ligands. A similar approach should be appliable to evaluate the internal polarity of the LBPs of other receptors.
キーワード
RXR
Fluorescence
Solvatochromism
Binding assay
備考
© 2023 Elsevier Ltd. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/
This fulltext file will be available in Nov. 2025.
発行日
2023-11-15
出版物タイトル
Bioorganic & Medicinal Chemistry Letters
96巻
出版者
Elsevier BV
開始ページ
129536
ISSN
0960-894X
NCID
AA1079577X
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2023 Elsevier Ltd.
論文のバージョン
author
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1016/j.bmcl.2023.129536
ライセンス
https://creativecommons.org/licenses/by-nc-nd/4.0/
助成機関名
Okayama Foundation for Science and Technology
Kobayashi Foundation